Patient-Reported Outcomes Following Discontinuation of Methotrexate in Patients with Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab: Results from a Randomized Controlled Trial

被引：0
|
作者：
Kremer, Joel [1 ]
Rigby, William F. C. [2 ]
Singer, Nora [3 ]
Birchwood, Christine [4 ]
Gill, Darcy [4 ]
Reiss, William [4 ]
Best, Jennie [4 ]
Pei, Jinglan [4 ]
Michalska, Margaret [4 ]
机构：
[1] Albany Med Coll, Albany, NY 12208 USA
[2] Geisel Sch Med Dartmouth, Lebanon, NH USA
[3] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[4] Genentech Inc, San Francisco, CA 94080 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
MONOTHERAPY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2460
引用
收藏
页数：3
相关论文
共 50 条
  • [31] UPADACITINIB IMPROVES PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: RESULTS FROM SELECT-COMPARE
    Strand, Vibeke
    Bergman, Martin
    Tundia, Namita
    Ostor, Andrew
    Durez, Patrick
    Song, In-Ho
    Enejosa, Jose Jeffrey
    Schlacher, Casey
    Song, Yan
    Fleischmann, Roy
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 738 - 739
  • [32] OUTCOMES OF THE RAPID DOSE ESCALATION OF METHOTREXATE IN JAPANESE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS; RESULTS FROM A RANDOMIZED CONTROLLED TRIAL
    Tsutsumino, M.
    Sakai, R.
    Kihara, M.
    Amano, K.
    Yoshimi, R.
    Inoo, M.
    Dobashi, H.
    Sugihara, T.
    Hidaka, T.
    Kohsaka, H.
    Miyasaka, N.
    Harigai, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 265 - 266
  • [33] An Examination of Patient-Reported Outcomes Data from a Randomized Trial Examining Etanercept and Methotrexate as Monotherapy or in Combination in Patients with Psoriatic Arthritis
    Strand, Vibeke
    Mease, Philip
    Maksabedian, Ervant
    Stolshek, Bradley
    Liu, Lyrica
    Collier, David
    Kricorian, Gregory
    Merola, Joseph
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [34] Tofacitinib with and without Methotrexate Versus Adalimumab with Methotrexate for the Treatment of Rheumatoid Arthritis: Patient-Reported Outcomes from a Phase 3b/4 Randomized Trial
    Strand, Vibeke
    Mysler, Eduardo
    Moots, Robert J.
    Wallenstein, Gene
    DeMasi, Ryan
    Luo, Zhen
    Soma, Koshika
    Iikuni, Noriko
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [35] Impact Of Etanercept-Methotrexate Treatment Withdrawal On Patient-Reported Outcomes In Patients With Early Rheumatoid Arthritis (PRIZE Trial)
    Wiland, Piotr
    Combe, B.
    FitzGerald, Oliver M.
    Tahir, Hasan
    Gaylord, Stefanie
    Williams, Theresa
    Pedersen, Ronald
    Bukowski, Jack
    Vlahos, Bonnie
    Kotak, Sameer
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1008 - S1009
  • [36] Olokizumab Improves Patient Reported Outcomes in Moderate to Severely Active Rheumatoid Arthritis Patients Inadequately Controlled by Methotrexate (MTX-IR): Results from the Phase III Randomized Controlled Trial
    Strand, Vibeke
    Nasonov, Evgeny
    Lisitsyna, Tatiana
    Lila, Alexander
    Kuzkina, Sofia
    Samsonov, Mikhail
    Feist, Eugen
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 611 - 612
  • [37] Effect of Dose Escalation of Subcutaneous Tocilizumab on Disease Activity in Patients with Rheumatoid Arthritis in a Randomized Controlled Trial
    Singer, Nora G.
    Mohan, Shalini V.
    Yourish, Jeffrey
    Han, Jian
    Edwardes, Michael
    Michalska, Margaret
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [38] Upadacitinib Monotherapy Improves Patient-Reported Outcomes in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate
    Strand, Vibeke
    Buch, Maya
    Tundia, Namita
    Camp, Heidi S.
    Suboticki, Jessica
    Goldschmidt, Debbie
    Wells, Alvin F.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [39] EFFECT OF DOSE ESCALATION OF SUBCUTANEOUS TOCILIZUMAB ON DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A RANDOMIZED CONTROLLED TRIAL
    Singer, N.
    Mohan, S.
    Han, J.
    Edwardes, M.
    Michalska, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1126 - 1126
  • [40] Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis
    Leslie R. Harrold
    Ani John
    George W. Reed
    Tmirah Haselkorn
    Chitra Karki
    YouFu Li
    Jennie Best
    Steve Zlotnick
    Joel M. Kremer
    Jeffrey D. Greenberg
    Rheumatology and Therapy, 2017, 4 : 405 - 417
12345